“…PML was originally identified as the fusion partner with the retinoic acid receptor RARalpha in leukemic blasts from patients suffering from acute promyelocytic leukemia (APL), leading to disrupted PML-NBs (Melnick and Licht, 1999). Accumulating evidence indicates that PML-NBs play regulatory roles in cellular processes such as cell growth (Fagioli et al, 1998;Cohen et al, 2001), chromatin remodeling (Amin et al, 2001), cellular differentiation (Drouin et al, 2001), protein degradation (Lallemand-Breitenbach et al, 2001), transcriptional regulation (Li et al, 2000;Zhong et al, 2000), antiviral response (Everett, 2001;Regad and Chelbi-Alix, 2001), cellular senescence (Ferbeyre et al, 2000;Pearson et al, 2000;Bischof et al, 2002;Langley et al, 2002), tumor suppression (reviewed by Salomoni and Pandolfi (2002)), DNA repair (Bischof et al, 2001;Carbone et al, 2002) and apoptosis (Wang et al, 1998;Fogal et al, 2000;Guo et al, 2000;D'Orazi et al, 2002;Hofmann et al, 2002).…”